Gründer, G <br/><br/>
Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.  [electronic resource] 

 -  Pharmacopsychiatry  Feb 2006 
 - S21-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0176-3679 
<br/><br/><label>Standard No.: </label>10.1055/s-2006-931485  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--adverse effects<br/>Aripiprazole<br/>Cerebral Cortex--drug effects<br/>Corpus Striatum--drug effects<br/>Dopamine Agonists--adverse effects<br/>Humans<br/>Limbic System--drug effects<br/>Mesencephalon--drug effects<br/>Neural Pathways--drug effects<br/>Piperazines--adverse effects<br/>Quinolones--adverse effects<br/>Receptors, Dopamine D2--agonists<br/>Schizophrenia--diagnosis<br/>Schizophrenic Psychology<br/>Serotonin 5-HT2 Receptor Antagonists<br/>Treatment Outcome